Surgical resection of hepatic metastases from neuroendocrine neoplasms: A systematic review

Surgical Oncology

Volumn 21, Issue 3, 2012, Pages e131-e141

  Saxena, Akshat ^a   Chua, Terence C ^a   Perera, Marlon ^a   Chu, Francis ^a   Morris, David L ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Hepatic metastases; Liver resection; Neuroendocrine tumour; Partial hepatectomy; Progression; Survival

Indexed keywords

CANCER INVASION; CANCER MORTALITY; CANCER PROGNOSIS; CANCER SURGERY; CANCER SURVIVAL; CORRELATION ANALYSIS; FOLLOW UP; HUMAN; LENGTH OF STAY; LIVER FAILURE; LIVER METASTASIS; LIVER RESECTION; LYMPH NODE METASTASIS; NEUROENDOCRINE TUMOR; OUTCOME ASSESSMENT; OVERALL SURVIVAL; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; REVIEW; SAFETY; TREATMENT OUTCOME;

EID: 84864719738     PISSN: 09607404     EISSN: 18793320     Source Type: Journal    
DOI: 10.1016/j.suronc.2012.05.001     Document Type: Review

References (66)

1. B. Lawrence, B.I. Gustafsson, A. Chan, B. Svejda, M. Kidd, and I.M. Modlin The epidemiology of gastroenteropancreatic neuroendocrine tumors Endocrinol Metab Clin North Am 40 2011 1 18 [vii]
2. R.S. Chamberlain, D. Canes, K.T. Brown, L. Saltz, W. Jarnagin, and Y. Fong Hepatic neuroendocrine metastases: does intervention alter outcomes? J Am Coll Surgeons 190 2000 432 445
3. I.M. Modlin, K.D. Lye, and M.A. Kidd 5-decade analysis of 13,715 carcinoid tumors Cancer 97 2003 934 959
4. P.F. Quaedvlieg, O. Visser, C.B. Lamers, M.L. Janssen-Heijen, and B.G. Taal Epidemiology and survival in patients with carcinoid disease in The Netherlands. An epidemiological study with 2391 patients Ann Oncol 12 2001 1295 1300
5. C.J. Auernhammer, and B. Goke Therapeutic strategies for advanced neuroendocrine carcinomas of jejunum/ileum and pancreatic origin Gut 60 2011 1009 1021
6. I.M. Modlin, M. Pavel, M. Kidd, and B.I. Gustafsson Review article: somatostatin analogues in the treatment of gastroenteropancreatic neuroendocrine (carcinoid) tumours Aliment Pharmacol Ther 31 2010 169 188
7. J. Strosberg, and L. Kvols Antiproliferative effect of somatostatin analogs in gastroenteropancreatic neuroendocrine tumors World J Gastroenterol 16 2010 2963 2970
8. S. Pyronnet, C. Bousquet, S. Najib, R. Azar, H. Laklai, and C. Susini Antitumor effects of somatostatin Mol Cell Endocrinol 286 2008 230 237
9. A. Rinke, H.H. Muller, C. Schade-Brittinger, K.J. Klose, P. Barth, and M. Wied Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID study group J Clin Oncol 27 2009 4656 4663
10. U. Plockinger, and B. Wiedenmann Neuroendocrine tumors Biotherapy Best Pract Res Clin Endocrinol Metab 21 2007 145 162
11. M.L. Fjallskog, E.T. Janson, U.G. Falkmer, M.H. Vatn, K.E. Oberg, and B.K. Eriksson Treatment with combined streptozotocin and liposomal doxorubicin in metastatic endocrine pancreatic tumors Neuroendocrinology 88 2008 53 58
12. E. Vilar, R. Salazar, J. Perez-Garcia, J. Cortes, K. Oberg, and J. Tabernero Chemotherapy and role of the proliferation marker Ki-67 in digestive neuroendocrine tumors Endocr Relat Cancer 14 2007 221 232
13. E. Raymond, L. Dahan, J.L. Raoul, Y.J. Bang, I. Borbath, and C. Lombard-Bohas Sunitinib malate for the treatment of pancreatic neuroendocrine tumors N Engl J Med 364 2011 501 513
14. J.C. Yao, M.H. Shah, T. Ito, C.L. Bohas, E.M. Wolin, and E. Van Cutsem Everolimus for advanced pancreatic neuroendocrine tumors N Engl J Med 364 2011 514 523
15. A. Saxena, T.C. Chua, L. Bester, A. Kokandi, and D.L. Morris Factors predicting response and survival after yttrium-90 radioembolization of unresectable neuroendocrine tumor liver metastases: a critical appraisal of 48 cases Ann Surg 251 5 2010 910 916
16. A.S. Kennedy, W.A. Dezarn, P. McNeillie, D. Coldwell, C. Nutting, and D. Carter Radioembolization for unresectable neuroendocrine hepatic metastases using resin 90Y-microspheres: early results in 148 patients Am J Clin Oncol 31 2008 271 279
17. S. Gupta, M.M. Johnson, R. Murthy, K. Ahrar, M.J. Wallace, and D.C. Madoff Hepatic arterial embolization and chemoembolization for the treatment of patients with metastatic neuroendocrine tumors: variables affecting response rates and survival Cancer 104 2005 1590 1602
18. B.K. Eriksson, E.G. Larsson, B.M. Skogseid, A.M. Lofberg, L.E. Lorelius, and K.E. Oberg Liver embolizations of patients with malignant neuroendocrine gastrointestinal tumors Cancer 83 1998 2293 2301
19. D.J. Kwekkeboom, W.W. de Herder, B.L. Kam, C.H. van Eijck, M. van Essen, and P.P. Kooij Treatment with the radiolabeled somatostatin analog [177Lu-DOTA0, Tyr3]octreotate: toxicity, efficacy, and survival J Clin Oncol 26 2008 2124 2130
20. M.H. Kulke, H.-J. Lenz, N.J. Meropol, J. Posey, D.P. Ryan, and J. Picus Activity of sunitinib in patients with advanced neuroendocrine tumors J Clin Oncol 26 2008 3403 3410
21. J.C. Yao, M. Hassan, A. Phan, C. Dagohoy, C. Leary, and J.E. Mares One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States J Clin Oncol 26 2008 3063 3072
22. E.W. McDermott, B. Guduric, and M.F. Brennan Prognostic variables in patients with gastrointestinal carcinoid tumours Br J Surg 81 1994 1007 1009
23. A. Frilling, G.C. Sotiropoulos, J. Li, O. Kornasiewicz, and U. Plockinger Multimodal management of neuroendocrine liver metastases HPB (Oxford) 12 2010 361 379
24. C. Durante, H. Boukheris, C. Dromain, P. Duvillard, S. Leboulleux, and D. Elias Prognostic factors influencing survival from metastatic (stage IV) gastroenteropancreatic well-differentiated endocrine carcinoma Endocr Relat Cancer 16 2009 585 597
25. S.C. Mayo, M.C. de Jong, C. Pulitano, B.M. Clary, S.K. Reddy, and T.C. Gamblin Surgical management of hepatic neuroendocrine tumor metastasis: results from an international multi-institutional analysis Ann Surg Oncol 2010
26. J.M. Sarmiento, G. Heywood, J. Rubin, D.M. Ilstrup, D.M. Nagorney, and F.G. Que Surgical treatment of neuroendocrine metastases to the liver: a plea for resection to increase survival J Am Coll Surg 197 2003 29 37
27. A. Saxena, T.C. Chua, A. Sarkar, F. Chu, W. Liauw, and J. Zhao Progression and survival results after radical hepatic metastasectomy of indolent advanced neuroendocrine neoplasms (NENs) supports an aggressive surgical approach Surgery 2010
28. E.S. Glazer, J.F. Tseng, W. Al-Refaie, C.C. Solorzano, P. Liu, and K.A. Willborn Long-term survival after surgical management of neuroendocrine hepatic metastases HPB (Oxford) 12 2010 427 433
29. A. Frilling, J. Li, E. Malamutmann, K.W. Schmid, A. Bockisch, and C.E. Broelsch Treatment of liver metastases from neuroendocrine tumours in relation to the extent of hepatic disease Br J Surg 96 2009 175 184
30. C.S. Cho, D.M. Labow, L. Tang, D.S. Klimstra, A.G. Loeffler, and G.E. Leverson Histologic grade is correlated with outcome after resection of hepatic neuroendocrine neoplasms Cancer 113 2008 126 134
31. C.S. Landry, C.R. Scoggins, K.M. McMasters, and R.C. Martin 2nd Management of hepatic metastasis of gastrointestinal carcinoid tumors J Surg Oncol 97 2008 253 258
32. D. Gomez, H.Z. Malik, A. Al-Mukthar, K.V. Menon, G.J. Toogood, and J.P. Lodge Hepatic resection for metastatic gastrointestinal and pancreatic neuroendocrine tumours: outcome and prognostic predictors HPB (Oxford) 9 2007 345 351
33. T. Hibi, T. Sano, Y. Sakamoto, Y. Takahashi, N. Uemura, and H. Ojima Surgery for hepatic neuroendocrine tumors: a single institutional experience in Japan Jpn J Clin Oncol 37 2007 102 107
34. S.K. Reddy, A.S. Barbas, C.E. Marroquin, M.A. Morse, P.C. Kuo, and B.M. Clary Resection of noncolorectal nonneuroendocrine liver metastases: a comparative analysis J Am Coll Surg 204 2007 372 382
35. D.A. Osborne, E.E. Zervos, J. Strosberg, B.A. Boe, M. Malafa, and A.S. Rosemurgy Improved outcome with cytoreduction versus embolization for symptomatic hepatic metastases of carcinoid and neuroendocrine tumors Ann Surg Oncol 13 2006 572 581
36. S. Musunuru, H. Chen, S. Rajpal, N. Stephani, J.C. McDermott, and K. Holen Metastatic neuroendocrine hepatic tumors: resection improves survival Arch Surg 141 2006 1000 1004 discussion 1005
37. J.G. Touzios, J.M. Kiely, S.C. Pitt, W.S. Rilling, E.J. Quebbeman, and S.D. Wilson Neuroendocrine hepatic metastases: does aggressive management improve survival? Ann Surg 241 2005 776 783 discussion 783-775
38. C.D. Knox, I.D. Feurer, P.E. Wise, L.W. Lamps, J. Kelly Wright, and R.S. Chari Survival and functional quality of life after resection for hepatic carcinoid metastasis J Gastrointest Surg 8 2004 653 659
39. J.A. Norton, R.S. Warren, M.G. Kelly, M.B. Zuraek, and R.T. Jensen Aggressive surgery for metastatic liver neuroendocrine tumors Surgery 134 2003 1057 1063 discussion 1063-1055
40. D. Elias, P. Lasser, M. Ducreux, P. Duvillard, J.F. Ouellet, and C. Dromain Liver resection (and associated extrahepatic resections) for metastatic well-differentiated endocrine tumors: a 15-year single center prospective study Surgery 133 2003 375 382
41. M.H. Chung, J. Pisegna, M. Spirt, A.E. Giuliano, W. Ye, and K.P. Ramming Hepatic cytoreduction followed by a novel long-acting somatostatin analog: a paradigm for intractable neuroendocrine tumors metastatic to the liver Surgery 130 2001 954 962
42. J. Coppa, A. Pulvirenti, M. Schiavo, R. Romito, P. Collini, and M. Di Bartolomeo Resection versus transplantation for liver metastases from neuroendocrine tumors Transplant Proc 33 2001 1537 1539
43. K.A. Yao, M.S. Talamonti, A. Nemcek, P. Angelos, H. Chrisman, and J. Skarda Indications and results of liver resection and hepatic chemoembolization for metastatic gastrointestinal neuroendocrine tumors Surgery 130 2001 677 682 discussion 682-675
44. H. Nave, E. Mossinger, H. Feist, H. Lang, and H. Raab Surgery as primary treatment in patients with liver metastases from carcinoid tumors: a retrospective, unicentric study over 13 years Surgery 129 2001 170 175
45. G.L. Grazi, M. Cescon, F. Pierangeli, G. Ercolani, A. Gardini, and A. Cavallari Highly aggressive policy of hepatic resections for neuroendocrine liver metastases Hepatogastroenterology 47 2000 481 486
46. D. Jaeck, E. Oussoultzoglou, P. Bachellier, P. Lemarque, J.C. Weber, and H. Nakano Hepatic metastases of gastroenteropancreatic neuroendocrine tumors: safe hepatic surgery World J Surg 25 2001 689 692
47. H. Chen, J.M. Hardacre, A. Uzar, J.L. Cameron, and M.A. Choti Isolated liver metastases from neuroendocrine tumors: does resection prolong survival? J Am Coll Surg 187 1998 88 92 discussion 92-83
48. H. Ahlman, G. Westberg, B. Wangberg, O. Nilsson, U. Tylen, and T. Schersten Treatment of liver metastases of carcinoid tumors World J Surg 20 1996 196 202
49. B. Wangberg, G. Westberg, U. Tylen, L. Tisell, S. Jansson, and O. Nilsson Survival of patients with disseminated midgut carcinoid tumors after aggressive tumor reduction World J Surg 20 1996 892 899 discussion 899
50. B. Dousset, O. Saint-Marc, J. Pitre, O. Soubrane, D. Houssin, and Y. Chapuis Metastatic endocrine tumors: medical treatment, surgical resection, or liver transplantation World J Surg 20 1996 908 914 discussion 914-905
51. F.G. Que, D.M. Nagorney, K.P. Batts, L.J. Linz, and L.K. Kvols Hepatic resection for metastatic neuroendocrine carcinomas Am J Surg 169 1995 36 42 discussion 42-33
52. G.P. McEntee, D.M. Nagorney, L.K. Kvols, C.G. Moertel, and C.S. Grant Cytoreductive hepatic surgery for neuroendocrine tumors Surgery 108 1990 1091 1096
53. S.A. Gulec, T.S. Mountcastle, D. Frey, J.D. Cundiff, E. Mathews, and L. Anthony Cytoreductive surgery in patients with advanced-stage carcinoid tumors Am Surg 68 2002 667 671 discussion 671-662
54. M.A. Kouvaraki, J.A. Ajani, P. Hoff, R. Wolff, D.B. Evans, and R. Lozano Fluorouracil, doxorubicin, and streptozocin in the treatment of patients with locally advanced and metastatic pancreatic endocrine carcinomas J Clin Oncol 22 2004 4762 4771
55. P.C. Simmonds, J.N. Primrose, J.L. Colquitt, O.J. Garden, G.J. Poston, and M. Rees Surgical resection of hepatic metastases from colorectal cancer: a systematic review of published studies Br J Cancer 94 2006 982 999
56. D.S. Klimstra, I.R. Modlin, D. Coppola, R.V. Lloyd, and S. Suster The pathologic classification of neuroendocrine tumors: a review of nomenclature, grading, and staging systems Pancreas 39 2010 707 712
57. L. Sobin, M. Gospodarowicz, and C. Wittekind UICC International Union Against Cancer. TNM classification of malignant tumors 2010 Wiley-Blackwell Oxford
58. J. Eriksson, P. Stalberg, A. Nilsson, J. Krause, C. Lundberg, and B. Skogseid Surgery and radiofrequency ablation for treatment of liver metastases from midgut and foregut carcinoids and endocrine pancreatic tumors World J Surg 32 2008 930 938
59. M. Tachezy, H. Zander, A.H. Marx, F. Gebauer, T. Rawnaq, and J.T. Kaifi ALCAM (CD166) expression as novel prognostic biomarker for pancreatic neuroendocrine tumor patients J Surg Res 170 2011 226 232
60. K.B. Long, A. Srivastava, M.S. Hirsch, and J.L. Hornick PAX8 expression in well-differentiated pancreatic endocrine tumors: correlation with clinicopathologic features and comparison with gastrointestinal and pulmonary carcinoid tumors Am J Surg Pathol 34 2010 723 729
61. S.U. Goebel, M. Iwamoto, M. Raffeld, F. Gibril, W. Hou, and J. Serrano Her-2/neu expression and gene amplification in gastrinomas: correlations with tumor biology, growth, and aggressiveness Cancer Res 62 2002 3702 3710
62. J. Rosenau, M.J. Bahr, R. von Wasielewski, M. Mengel, H.H. Schmidt, and B. Nashan Ki67, E-cadherin, and p53 as prognostic indicators of long-term outcome after liver transplantation for metastatic neuroendocrine tumors Transplantation 73 2002 386 394
63. S.K. Reddy, and B.M. Clary Neuroendocrine liver metastases Surg Clin North Am 90 2010 853 861
64. Y.P. Le Treut, J.R. Delpero, B. Dousset, D. Cherqui, P. Segol, and G. Mantion Results of liver transplantation in the treatment of metastatic neuroendocrine tumors. A 31-case French multicentric report Ann Surg 225 1997 355 364
65. T. Lehnert Liver transplantation for metastatic neuroendocrine carcinoma: an analysis of 103 patients Transplantation 66 1998 1307 1312
66. F.G. van Vilsteren, E.S. Baskin-Bey, D.M. Nagorney, S.O. Sanderson, W.K. Kremers, and C.B. Rosen Liver transplantation for gastroenteropancreatic neuroendocrine cancers: defining selection criteria to improve survival Liver Transpl 12 2006 448 456